COVID-19 时代辅助生殖技术中的公正与自主
本文讨论在 COVID-19 大流行初期,生育服务因 ESHRE、ASRM 及 HFEA 指南而被大幅限制或暂停,虽符合公共卫生优先原则,但给患者带来显著痛苦。文章围绕辅助生殖技术中的公正与自主,分析潜在冲突与解决方式。
要点
- 疫情初期生育服务大幅限制或暂停,依据 ESHRE、ASRM 及 HFEA 指南。
- 暂停 ART 虽符合公共卫生伦理,但患者痛苦显著,请愿获超 21,000 签名。
- 当前挑战在于平衡公共卫生威胁下的伦理考量与患者自主。
核心结论
- 疫情初期暂停 ART 符合伦理,因公共卫生目标优先于个体患者自主,但当前生育领域面临更复杂的伦理平衡挑战。
研究设计与样本
- 本文为论述性文章,讨论 ART 背景下的公正与自主、潜在冲突及解决方式。
主要发现
- 生育服务因 ESHRE、ASRM 指南及 HFEA 指令 GD0014 而大幅限制或暂停。
- 反对 ASRM 建议的请愿已收集超过 21,000 个签名,显示患者显著痛苦。
临床怎么用
- 临床决策需兼顾公共卫生目标与患者个体自主,关注疫情下生育服务的伦理平衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fertility services were significantly curtailed or suspended as an initial response to the coronavirus (COVID-19) pandemic earlier this year, following guidance from European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) as well as a General Direction (GD0014) issued by the Human Fertilisation and Embryo Authority (HFEA). It is difficult to argue with triage of medical care and resources in the face of anticipated overwhelming demand, but this situation resulted in considerable distress, as shown by a change.org petition opposing ASRM recommendations, which has gathered over 21,000 signatures to date. Although halting assisted reproductive technology (ART) as the pandemic unfolded was ethical because public health goals superseded individual patient autonomy, the fertility sector now faces a greater challenge balancing ethical considerations in an era characterized by the ongoing threat of COVID-19. This article discusses justice and autonomy in the context of ART, potential conflicts and resolutions.
引用
- Martins da Silva SJ, Campo-Engelstein L. Assisted reproductive technology, justice and autonomy in an era of COVID-19. Reprod Biomed Online. 2020. PMID: 33279418. doi:10.1016/j.rbmo.2020.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。